EU Fast-Track Success For BioMarin’s Valrox But Not For Amarin’s Vascepa

Filings For Both Products Are Due By Year End

 
• By Maureen Kenny
Race_Track_Stopwatch
The EMA is to review BioMarin's planned marketing application more quickly • Source: Shutterstock

More from Europe

More from Geography